🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium
Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.
The sector has been re-rated somewhat, and investors are anticipating lower interest rates going foward. In its recent earnings release, BAT indicated organic revenue growth would land at the top of its 1-2% range. Though not a formal guidance raise, the comment implies modest improvement. However, organic operating profit guidance was held at 1.5-2.5% -- a clear sign the company will continue investing in its next generation platform. With consumers adopting new products quickly and competition intensifying, sustained R&D is essential. To fund this, BAT must keep maximizing profits from its traditional cigarette business, now aided by a recovery in US revenues, the first positive result since 2022. The company maintained it guidance on currency, with a transactional headwind of 1.5% and translation hit of 4%. Consensus now sees adjusted EPS declining mid-single digits, partly offset by share buybacks. Valuation has gone from about 8X earnings to 12X earnings, with the dividend now 5.01%. Business is improving somewhat, but the usual risks remain. We would consider the 72% one-year gain 'a bit much' here and certainly would not expect these returns to be sustainable. While we would still consider it a solid income stock, we would be fine taking some off the table.
Unlock Premium - Try 5i Free